CASC3 and plasma cell myeloma: As we show in a schematic illustration of the potential anti-myeloma mechanism of BTZ and PIN (Figure 7), MM apoptotic induction from PIN/BTZ treatment likely occurs from the proteasome inhibition and oxidative stress induced by BTZ [14,15,50].